Stilbenes in Cancer Therapy: Molecular Targets, Progress
In the relentless quest for novel cancer therapies, a potent class of compounds known as stilbenes has recently captured the ...
Tag: Tumor microenvironment modulation
Reticulocalbin-1: Biomarker and Therapy Target in RCC
Clear cell renal cell carcinoma (ccRCC) stands as the most common subtype of kidney cancer, notorious for its aggressive clinical ...
Cutting-Edge Oncolytic Virus and Immunotherapy Synergies Herald New Era in Cancer Treatment
The landscape of cancer treatment is undergoing a profound transformation, driven in large part by the innovative integration of oncolytic ...
Unraveling PAD2-Mediated Histone Citrullination: A Key Driver in Pancreatic Cancer Progression
Peptidyl-arginine deiminase 2 (PAD2) has emerged as a pivotal enzyme driving the progression of pancreatic ductal adenocarcinoma (PDAC), one of ...
Promising Neoadjuvant Immunochemoradiotherapy for MSS/pMMR Rectal Cancer
In recent years, the landscape of oncology has undergone a transformative evolution, particularly in the treatment of rectal cancer. Traditional ...
Breaking Barriers: New Checkpoint Targets Empower NK Cells to Transform Cancer Immunotherapy
In the rapidly evolving landscape of cancer immunotherapy, recent groundbreaking research delves into an underexplored yet pivotal component of the ...
Ivonescimab Sheds Light on NSCLC Immuno-Angiogenesis
The landscape of non-small cell lung cancer (NSCLC) treatment has undergone a radical transformation in recent years, driven by advances ...
SIM2 Drives Malignant Behavior in Endometrial Cancer
A newly published study delves into the molecular underpinnings of endometrial carcinoma (EC), revealing a pivotal role for the SIM ...
